Researchers reported encouraging vision gains from the first-in-human trial of an in vivo CRISPR therapy for inherited blindness. The therapy targeted a severe retinal disorder and produced measurable improvements in…
Scientists have introduced a plant-based plastic that breaks down within weeks under favorable home conditions. The material decomposes without industrial composting, specialized facilities, or high heat. Researchers designed the plastic…
Metallics moved from occasional accent to headlining statement across holiday collections and city sidewalks. Designers, retailers, and creators leveraged high-shine surfaces to deliver festive impact with modern edge. Shoppers embraced…
Streaming platforms are introducing provenance labels to identify AI-generated music across catalogs. The move follows fierce artist backlash over voice cloning and undisclosed synthetic tracks. Services want to preserve listener…
Antimicrobial resistance threatens modern medicine and global health security. Drug-resistant superbugs already complicate routine surgeries and cancer therapies. Traditional discovery pipelines have slowed as resistance has surged worldwide. Artificial intelligence…
Researchers have unveiled a blood test that detects early-stage pancreatic cancer with striking accuracy. The assay analyzes multiple biological signals in a single draw. It aims to identify cancer before…
Researchers have unveiled a sodium-ion battery that performs on par with mainstream lithium cells. Their findings suggest real competition for lithium iron phosphate batteries. The results could unlock cheaper electric…
A CRISPR-based antiviral platform has advanced through preclinical testing with promising breadth and potency. Researchers report protection against multiple respiratory viruses in cell cultures and animal models. The approach targets…
Gene-edited bananas are showing resistance to Panama disease, reshaping hopes for global crop security. Scientists are using precise tools to strengthen banana immunity. Early trials indicate durable resistance without sacrificing…
Scientists report early human trial results for a universal influenza vaccine candidate with encouraging breadth and durability. The vaccine triggered antibodies that recognized diverse flu strains, including viruses not closely…
